Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER networkLoreta A. Kondili, Stefano Vella, Daniela Caterina Amoruso et al.|PLoS ONE|2017Cited by 114
Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohortMaria Giovanna Quaranta, Loreta A. Kondili, Luigina Ferrigno et al.|BMC Infectious Diseases|2021Cited by 29
Liver Function Following Hepatitis C Virus Eradication by Direct Acting Antivirals in Patients With Liver Cirrhosis: Data from The PITER CohortMaria Giovanna Quaranta, Loreta A. Kondili, Luigina Ferrigno et al.|Research Square|2021Cited by 3
Multifactor risk evaluation in patients who have eradicated HCV infection: an interim analysis in the PITER cohortLoreta A. Kondili, Vincenza Calvaruso, Mg Quaranta et al.|Journal of Hepatology|2018Cited by 0
Analisi modellistica sulle conseguenze cliniche ed economiche del trattamento antivirale contro l’infezione cronica da HCV nella coorte reale PITER.Mg Quaranta, Luchino Chessa, Andrea Marcellusi et al.|UNICA IRIS Institutional Research Information System (University of Cagliari)|2018Cited by 0